Iradimed (IRMD) Non-Current Deferred Tax Liability (2013 - 2023)
Iradimed's (IRMD) quarterly Non-Current Deferred Tax Liability came in at $1.1 million in Q4 2023, up 78.48% quarter-over-quarter from $611269.0 in Q4 2018.
Powered by 
Analysis
Iradimed (IRMD) Non-Current Deferred Tax Liability (2013 - 2023) Analysis & Trends
Iradimed (IRMD) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $1.1 million the latest figure, recorded in Q4 2023.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $1.1 million in Q4 2023; TTM through Dec 2023 was $1.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $1.1 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $1.1 million for Q4 2023 at Iradimed, up from $611269.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $1.1 million in Q4 2023 and troughed at $1.1 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2018 | 611,269.00 |
| Dec 31, 2017 | 615,186.00 |
| Dec 31, 2016 | 660,636.00 |
| Dec 31, 2013 | 54,087.00 |